EPerot Bissell - Acadia Healthcare Independent Director
| ACHC Stock | USD 73.94 0.67 0.90% |
Director
Mr. E. Perot Bissell is Independent Director of the Acadia Healthcare Company Inc. Since 2016, Mr. Bissell was a Managing Partner of Egis Capital Partners, LLC, a private equity firm that invests in the security and protection industries. Mr. Bissell served as the Chairman and Chief Executive Officer of Next Generation Energy Logistics, LLC, an energy logistics development company, from 2013 to 2015. Before that, Mr. Bissell served as the Vice Chairman of Pilot Logistics Services, a provider of drilling and exploration support services, from September 2012 until July 2013. From 2006 to 2012, he served as Chief Executive Officer for Maxum Petroleum, Inc., an independent energy logistics company. Prior to that, Mr. Bissell was a Partner of Northwest Capital Appreciation, Inc., a merchant banking and private equity firm, and before that, the CoManaging Partner and Chief Financial Officer of SLP Capital, a specialty finance company since 2013.
| Age | 58 |
| Tenure | 11 years |
| Address | 6100 Tower Circle, Franklin, TN, United States, 37067 |
| Phone | 615 861 6000 |
| Web | https://www.acadiahealthcare.com |
Acadia Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0612 % which means that it generated a profit of $0.0612 on every $100 spent on assets. This is way below average. Acadia Healthcare's management efficiency ratios could be used to measure how well Acadia Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.0067. In addition to that, Return On Capital Employed is expected to decline to 0.06. At present, Acadia Healthcare's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 50.9 M, whereas Total Assets are forecasted to decline to about 4.4 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Barry Smith | The Ensign Group | 64 | |
| Bruce Perkins | Amedisys | 64 | |
| Paul Abernathy | National HealthCare | 82 | |
| Richard LaRoche | National HealthCare | 74 | |
| Pascal Desroches | DaVita HealthCare Partners | 55 | |
| Nancy Schlichting | Encompass Health Corp | 66 | |
| Carol Davidson | DaVita HealthCare Partners | 60 | |
| Nadja West | Tenet Healthcare | 60 | |
| James Unruh | Tenet Healthcare | 74 | |
| John Chidsey | Encompass Health Corp | 58 | |
| Andrew Adams | National HealthCare | 72 | |
| Mark Brookner | US Physicalrapy | 76 | |
| Clayton Trier | US Physicalrapy | 69 | |
| Thomas Scully | Select Medical Holdings | 63 | |
| Christopher Reidy | Encompass Health Corp | 64 | |
| Kathleen Gilmartin | US Physicalrapy | 69 | |
| Leslye Katz | Encompass Health Corp | 66 | |
| James Dalton | Select Medical Holdings | 73 | |
| Tammy Romo | Tenet Healthcare | 58 | |
| Meghan FitzGerald | Tenet Healthcare | 50 | |
| Charles Berg | DaVita HealthCare Partners | 63 | |
Management Performance
| Return On Equity | -0.0054 | ||||
| Return On Asset | 0.0612 |
Acadia Healthcare Leadership Team
Elected by the shareholders, the Acadia Healthcare's board of directors comprises two types of representatives: Acadia Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acadia. The board's role is to monitor Acadia Healthcare's management team and ensure that shareholders' interests are well served. Acadia Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acadia Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Laura Groschen, Chief Officer | ||
| Christopher Howard, Executive Vice President General Counsel, Secretary | ||
| Laurence Harrod, Ex Fin | ||
| William Petrie, Independent Director | ||
| David Duckworth, CFO, Chief Accounting Officer and Controller | ||
| Mark Palmenter, Chief Officer | ||
| Vicky Gregg, Director | ||
| Isa Diaz, Senior Affairs | ||
| Laurenc Harrod, Executive Vice President - Finance | ||
| Joey Jacobs, Chairman and CEO | ||
| Bill Priest, Chief Officer | ||
| Nasser MD, Operations Business | ||
| Christopher Hunter, CEO Director | ||
| Gretchen Hommrich, Vice Relations | ||
| Christopher Gordon, Director | ||
| Reeve Waud, Lead Director | ||
| Debra Osteen, CEO, Director | ||
| Brent Turner, President | ||
| Heather CPA, Chief Officer | ||
| EPerot Bissell, Independent Director | ||
| Wade Miquelon, Independent Director | ||
| Andrew Honeybone, VP Officer | ||
| David CFA, Chief Officer | ||
| William Grieco, Independent Director | ||
| Bruce Shear, Executive Vice Chairman | ||
| Kyle Lattner, Director | ||
| Randall Goldberg, Vice President - Business Development | ||
| Ronald Fincher, COO | ||
| Chris Gordon, Independent Director | ||
| John Hollinsworth, Executive Vice President of Operations | ||
| Hartley Rogers, Independent Director | ||
| Brian Farley, General VP | ||
| MD JD, Chief Officer |
Acadia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acadia Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0054 | ||||
| Return On Asset | 0.0612 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 8.4 B | ||||
| Shares Outstanding | 92.43 M | ||||
| Shares Owned By Insiders | 2.86 % | ||||
| Shares Owned By Institutions | 97.14 % | ||||
| Number Of Shares Shorted | 3.52 M | ||||
| Price To Earning | 25.67 X |
Acadia Healthcare Investors Sentiment
The influence of Acadia Healthcare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Acadia. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Acadia Healthcare's public news can be used to forecast risks associated with an investment in Acadia. The trend in average sentiment can be used to explain how an investor holding Acadia can time the market purely based on public headlines and social activities around Acadia Healthcare. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Acadia Healthcare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Acadia Healthcare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Acadia Healthcare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Acadia Healthcare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acadia Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acadia Healthcare's short interest history, or implied volatility extrapolated from Acadia Healthcare options trading.
Pair Trading with Acadia Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acadia Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acadia Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving together with Acadia Stock
| 0.72 | TFX | Teleflex Incorporated Earnings Call This Week | PairCorr |
| 0.8 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
Moving against Acadia Stock
| 0.79 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.65 | FLGC | Flora Growth Corp Buyout Trend | PairCorr |
The ability to find closely correlated positions to Acadia Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acadia Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acadia Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acadia Healthcare to buy it.
The correlation of Acadia Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acadia Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acadia Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acadia Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.Note that the Acadia Healthcare information on this page should be used as a complementary analysis to other Acadia Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Acadia Stock analysis
When running Acadia Healthcare's price analysis, check to measure Acadia Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acadia Healthcare is operating at the current time. Most of Acadia Healthcare's value examination focuses on studying past and present price action to predict the probability of Acadia Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acadia Healthcare's price. Additionally, you may evaluate how the addition of Acadia Healthcare to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Acadia Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Healthcare. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share (0.24) | Revenue Per Share 32.202 | Quarterly Revenue Growth 0.1 | Return On Assets 0.0612 |
The market value of Acadia Healthcare is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Acadia Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Healthcare's market value can be influenced by many factors that don't directly affect Acadia Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acadia Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acadia Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.